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Vitamin E refers to four tocopherols and four tocotrienols that
are exclusively synthesized by photosynthetic organisms.
While a-tocopherol is the most potent vitamin E compound, it is
not the main form consumed since the composition of most
major crops is dominated by g-tocopherol. Nutritional studies
show that populations of developed countries do not consume
enough vitamin E and that a large proportion of individuals
exhibit plasma a-tocopherol deﬁciency. Following the
identiﬁcation of vitamin E biosynthetic genes, several strategies
including metabolic engineering, classic breeding and mutation
breeding, have been undertaken to improve the vitamin E
content of crops. In addition to providing crops in which vitamin
E content is enhanced, these studies are revealing the
bottlenecks limiting its biosynthesis.
Address
University of Fribourg, Department of Biology, Chemin du muse´e, 10,
CH-1700 Fribourg, Switzerland
Corresponding author: Me`ne-Saffrane´, Laurent (laurent.mene-
saffrane@unifr.ch)
Introduction
Vitamin E encompasses eight organic compounds with a
chromanol ring substituted with one to three methyl
groups that are collectively called tocochromanols. Vita-
min E isoforms with a saturated prenyl side chain are
called tocopherols, while the ones with an unsaturated
prenyl side chain are named tocotrienols (Figure 1a & b).
Tocopherol and tocotrienol forms (a-, b-, g-, and d-) differ
by the number and position of methyl substituents on the
chromanol ring. The vitamin E activity of each form
differs greatly due to the different afﬁnities between
speciﬁc tocochromanols and the liver a-tocopherol trans-
fer protein, which preferentially binds a-tocopherol [1]
(Table 1). Other tocochromanols such as plastochroma-
nol-8 (PC-8; Figure 1c) and tocomonoenols (Figure 1d)
have been identiﬁed in edible plants regularly consumed
by humans [2,3]. The vitamin E activity of these latter
forms is unknown yet.
Vitamin E was originally identiﬁed as a nutritional factor
essential for animal reproduction [4]. Since, it has been
shown that vitamin E is a powerful lipid antioxidant that
protects cell membranes from the damaging effects
induced by free radicals [5,6]. In addition, several toco-
chromanol isoforms show beneﬁcial roles in delaying
brain aging [7], reducing the risk of developing
Alzheimer’s disease [7], or inhibiting lung cancer [8].
Tocopherols are found in virtually all photosynthetic
plants, notably in vegetable oil and nuts, whereas toco-
trienols are mainly encountered in monocot seeds.
Despite its wide availability, nutritional surveys clearly
demonstrate that a large portion of Western populations
do not meet the vitamin E recommended dietary allow-
ance [9,10,11]. While the long-term effects on health of
chronic vitamin E deﬁciency are not deﬁnitively estab-
lished for humans, the oxidative stress associated with
vitamin E deﬁciency strongly advocates for improving its
quality and quantity in the human diet.
Update on the tocochromanol biosynthetic pathway
Strategies implemented to enhance vitamin E content in
crops derive from our current knowledge of tocochroma-
nol biosynthesis, which has been recently reviewed
[12,13]. This section will brieﬂy summarize tocochroma-
nol metabolism and introduce vitamin E biosynthetic
genes recently identiﬁed (Figure 2).
Tocochromanols are amphipathic molecules composed of
a polar chromanol ring built around the phenolic com-
pound homogentisic acid (HGA), and a hydrophobic
isoprenoid side chain. HGA is produced from 4-hydro-
xyphenylpyruvate (HPP) by a p-hydroxyphenylpyruvate
dioxygenase (HPPD; Figure 2a). In plants, HPP derives
from tyrosine degradation that notably involves a speciﬁc
tyrosine aminotransferase [14]. In contrast, cyanobacteria
produce HPP directly from chorismate and/or prephenate
with a bifunctional chorismate mutase/prephenate dehy-
drogenase named TyrA [15,16].
The prenyl side chains of prenylquinols and tocochro-
manols all derive from geranylgeranyl pyrophosphate
(GGPP) produced by the plastidial methyl erythritol
phosphate (MEP) pathway (Figure 2b). Geranylgeranyl
pyrophosphate synthase (GGPPS) 11 was recently shown
to catalyze the biosynthesis of most plastid GGPP-
derived isoprenoids, including tocochromanols [17].
For tocotrienol synthesis, GGPP is directly condensed
with HGA. For solanesyl derivatives such as plastoquinol-
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9 (PQ-9) and PC-8, GGPP is converted into solanesyl
pyrophosphate (SPP) by solanesyl pyrophosphate
synthases [18]. Tocopherol synthesis requires the reduc-
tion of GGPP into phytyl pyrophosphate (PPP) by a
geranylgeranyl reductase (GGR). In vitro, GGR reduces
both free GGPP and geranylgeranylated chlorophyll a
(Figure 2c). Recently, the light-harvesting-like proteins
LIL3:1 and LIL3:2 were shown to be involved in
tocochromanol metabolism through their interaction
and stabilization of GGR proteins in the chloroplast
membrane [19]. In Arabidopsis seeds and leaves, tocoph-
erol synthesis mostly depends on the phytol kinase VTE5
and the phytyl phosphate kinase VTE6 that sequentially
phosphorylate phytol into PPP [20,21]. In senescent
leaves, the phytol used for tocopherol synthesis originates
mostly from chlorophyll hydrolysis [21]. In Arabidopsis
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Tocochromanol structures. Chemical structures of tocopherols (a), tocotrienols (b), plastochromanol-8 (c), and tocomonoenols (d). R1, R2,
R3 = CH3, a-tocochromanol; R1, R3 = CH3, R2 = H, b-tocochromanol; R2, R3 = CH3, R1 = H, g-tocochromanol; R3 = CH3, R1, R2 = H,
d-tocochromanol.
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seeds, chlorophyll degradation and recycling contributes
at least 60% to tocopherol synthesis [20]. In contrast, the
origin of phytol used for tocopherol synthesis in healthy
leaves is still an open question [22].
The committed step of tocochromanol biosynthesis is the
condensation of HGA with an isoprenoid side chain
mediated by various prenyltransferases. Tocotrienol syn-
thesis is initiated by a homogentisate geranylgeranyl-
transferase (HGGT), PC-8 synthesis by a homogentisate
solanesyltransferase (HST), and tocopherol synthesis by a
homogentisate phytyltransferase (HPT; Figure 2e). The
resulting methylprenylquinols are methylated by methyl-
transferase (MT) to form dimethylprenylquinols. Both
methyl- and dimethyl-geranylgeranyl- and phytyl-quinols
are cyclized by tocopherol cyclase (TC) to form d-toco-
chromanols and g-tocochromanols, respectively. These
isoforms are further methylated by the g-tocopherol
methyl transferase (g-TMT) to form b-tocochromanols
and a-tocochromanols, respectively. For solanesyl deri-
vatives, cyclization of PQ-9 by TC produces PC-8 that is
not further methylated in wild-type plants.
Vitamin E biofortiﬁcation through improving plant
tocopherol composition
The ﬁrst strategy that was assessed to enhance vitamin E
activity in plants consisted in improving plant tocochro-
manol composition by converting preexisting tocopherols
into forms exhibiting higher biological potency [23].
Indeed, seeds of the most abundantly consumed oilseed
crops (e.g., soybean, rapeseed, cotton, and oil palm) accu-
mulate primarily g-tocopherol, a form that has 10% of the
vitamin E activity of a-tocopherol (Table 1). Since
g-tocopherol is the direct precursor of a-tocopherol, its
conversion into a-tocopherol by g-TMT overexpression
should greatly enhance the vitamin E activity in a tissue.
This strategy was originally attempted in Arabidopsis in
which the g-TMT gene was introduced under a seed-
speciﬁc promoter [23]. While g-tocopherol dominated the
tocopherol composition of wild-type seeds (>95%),
a-tocopherol represented up to 95% of seed tocopherols
in the best transgenic event [23]. Subsequently, the
successful conversion of g-tocopherol into a-tocopherol
via g-TMT overexpression has been reported in many
other plants including soybean [24–27], shiso [28], lettuce
[29], mustard [30], maize [31], and tobacco [32]. Because
of the higher biological activity of a-tocopherol, most
g-TMT overexpressing crops exhibited 5–10 times higher
vitamin E activity than untransformed plants. In species
accumulating d-tocopherol, which has 3% of the vitamin
E activity of a-tocopherol, g-TMT overexpression also
enhanced its conversion into b-tocopherol, which at 50%
of the vitamin E activity of a-tocopherol is 16.6 times
more potent [23–27,30] (Figure 2 and Table 1). Because
the gain in vitamin E activity is very signiﬁcant and no
adverse effects on growth and fertility have been reported
in g-TMT overexpressing plants, this strategy is today
among the most effective for vitamin E biofortiﬁcation of
crops.
In addition to transgenic approaches, a-tocopherol
enrichment can also be achieved by traditional breeding
using natural high a-tocopherol alleles identiﬁed in crop
germplasms by QTL studies. While seeds of most soy-
bean varieties contain low a-tocopherol amounts (<10%
of the tocopherol pool), three varieties having up to 53%
of a-tocopherol were identiﬁed in soybean germplasm
[33]. QTL analysis showed that high a-tocopherol con-
tent correlated with higher expression of g-TMT3, a
soybean gene encoding a polypeptide that exhibits
81.8% similarity with the Arabidopsis g-TMT protein
[34]. Comparison of g-TMT3 promoter sequences
between high and standard a-tocopherol varieties identi-
ﬁed conserved polymorphisms within the promoter
regions of the high a-tocopherol varieties that might be
responsible for the higher g-TMT3 promoter activity.
This hypothesis was conﬁrmed in transgenic Arabidopsis
plants expressing the GUS reporter gene fused to g-TMT3
promoters originating from standard or high a-tocopherol
varieties [34]. Thus, soybean germplasm carries mono-
genic alleles that increase by at least ﬁvefold the
a-tocopherol content in seeds and could be introgressed
into standard varieties to improve their vitamin E content.
High a-tocopherol cultivars have been identiﬁed in other
crops including rice [35], maize [36,37], and rapeseed
[38]. Collectively, these high a-tocopherol natural var-
iants represent promising alternatives to transgenic crops,
notably for countries in which the production and/or
marketing of plant GMOs are currently banned.
Table 1
Vitamin E activity of natural and synthetic tocochromanols. The
biological activity of each tocochromanol form, given in IU/mg
and compared to the activity of a-tocopherol, has been calcu-
lated from the rat fetal resorption assay. Briefly, vitamin E-
depleted virgin females were mated with normal males. Preg-
nant females were subsequently fed with different doses of
specific vitamin E isomers during 21 days after which they were
sacrificed. The vitamin E biological activity was determined by
counting the number of living, dead, and resorbed fetuses. One
international unit (IU) corresponds to the vitamin E activity of
1 mg of the synthetic all-rac-a-tocopheryl acetate
Tocochromanol Activity (IU/mg) Activity (%)
a-Tocopherol 1.49 100
b-Tocopherol 0.75 50
g-Tocopherol 0.15 10
d-Tocopherol 0.05 3
a-Tocotrienol 0.45–0.75 30–50
b-Tocotrienol 0.08 5
g-Tocotrienol Below
detection
Below
detection
d-Tocotrienol Below
detection
Below
detection
all-rac-a-Tocopheryl acetate (synthetic) 1 67
RRR-a-Tocopheryl acetate (synthetic) 1.36 91
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Tocopherol biosynthetic precursor availability regulates
vitamin E accumulation
In order to identify the biosynthetic steps limiting toco-
chromanol accumulation in plants, tocopherol produc-
tion was investigated in cell cultures fed with metabolic
intermediates [15,39,40]. While these studies concluded
that both HGA and phytol had the greatest effects on
vitamin E biosynthesis, their conclusions differ on which
compound is the most limiting. In safﬂower cell cultures,
phytol feeding signiﬁcantly increased tocopherol pro-
duction after 3 days of incubation, while HGA supple-
mentation had no effect [39]. After fourteen days of
treatment, HGA feeding increased tocopherol content
by 3.3 times, while phytol supplementation increased
tocopherol content by 18.4 times [39]. These data indi-
cate that the availability of both tocopherol precursors
restricts vitamin E biosynthesis, with phytol being the
most limiting. In contrast, in sunﬂower suspension cells,
HGA feeding stimulated tocopherol accumulation
(30%), while phytol supplementation had no effect
[40]. Finally, in soybean suspension cultures, tocopherol
content increased twofold in response to either HGA or
phytol feeding, and ﬁvefold when both precursors were
added simultaneously [15]. These studies collectively
showed that the availability of tocochromanol biosyn-
thetic precursor(s) signiﬁcantly limits vitamin E accu-
mulation in plants and suggest that enhancing the met-
abolic pathway(s) producing them in planta might
improve vitamin E synthesis.
Vitamin E biofortiﬁcation through metabolic engineering
of tocopherol precursors
The second strategy aiming at improving crop vitamin E
activity involves increasing the global production of toco-
chromanols. This was attempted by overexpressing
tocopherol core biosynthetic genes (VTE), and biosyn-
thetic genes producing the aromatic head and/or the
isoprenoid side chain of prenylquinols.
Transgenic approaches targeting vitamin E core biosynthetic
genes (VTE)
The committed step of the tocochromanol pathway is
catalyzed by prenyltransferases that condense HGA with
either PPP (tocopherols) or GGPP (tocotrienols).
Attempts to increase tocochromanols by overexpressing
prenyltransferases in plants led to contrasting results
depending on the selected gene, the plant organ or
species, and the study. Overexpression of HPT genes
in canola and soybean did not signiﬁcantly increase seed
tocopherol content [15]. In Arabidopsis, HPT overexpres-
sion increased seed tocopherols from 40% to 100%
depending on the study, indicating that this activity is
at least partially limiting in Arabidopsis seeds [15,41,42].
In leaves, HPT overexpression induced a 3.6 fold and
4.4 fold increase of tocopherol content in tomato and
Arabidopsis, respectively [42,43]. Together, these indi-
cate that, while the HPT activity is not the major bottle-
neck in seed tocopherol metabolism, it clearly restricts
tocopherol synthesis in leaves.
Overexpression of HGGT genes increased tocochromanol
content up to 5 times in tobacco leaves, up to 15 times in
Arabidopsis leaves, and 7–18 times in maize kernels [44–
46]. In agreement with the preference of HGGT for
GGPP, newly synthesized tocochromanols were exclu-
sively tocotrienols. In Arabidopsis and tobacco leaves
overexpressing HGGT, tocopherol content was not altered
despite the massive accumulation of tocotrienols [44,46].
Since tocopherol and tocotrienol biosynthetic pathways
both share HGA as a common precursor, these data
indicate that Arabidopsis and tobacco leaves can sustain
tocochromanol synthesis up to 15 and 5 times the WT
tocochromanol levels, respectively, without HGA being
limiting. In transgenic maize kernels the situation is
slightly different. While maize HGGT overexpressors
containing 7 times higher tocotrienol content showed
unchanged tocopherol amounts, lines accumulating
18 times more tocotrienols had an 18% reduction in
tocopherols [44,45]. These indicate that in maize, HGA
is not limiting up to a certain enhancement of tocochro-
manol metabolism, but does become limiting at higher
levels. In addition, these data also show that HGGT
activity is clearly limiting tocotrienol biosynthesis in
maize kernels.
Transgenic approaches targeting HGA availability
Since HGA feeding improved tocopherol content in some
studies, transgenic approaches aiming at increasing
(Figure 2 Legend) Biosynthetic pathways involved in tocochromanol biosynthesis. Biosynthetic pathways forming the tocochromanol precursors
homogentisic acid (HGA, a), geranylgeranyl pyrophosphate (GGPP, b), phytyl pyrophosphate (PPP) and solanesyl pyrophosphate (SPP, c), as well
as prenylquinols and tocochromanols (e). The chemical structures of HGA, GGPP, PPP and SPP are shown (d). Compound abbreviations:
DMAPP, dimethylallyl pyrophosphate; DMGGBQ: 2,3-dimethyl-6-geranylgeranyl-1,4-benzoquinol; DMPBQ, 2,3-dimethyl-6-phytyl-1,4-benzoquinol;
G3P, D-glyceraldehyde-3-phosphate; HPP, 4-hydroxyphenylpyruvate; IPP, isopentenyl pyrophosphate; MGGBQ, 2-methyl-6-geranylgeranyl-1,4-
benzoquinol; MPBQ, 2-methyl-6-phytyl-1,4-benzoquinol; MSBQ, 2-methyl-6-solanesyl-1,4-benzoquinol; PC-8, plastochromanol-8; PQ-9,
plastoquinol-9; SAM: S-adenosyl-methionine; Tyr, tyrosine. Biosynthetic enzyme abbreviations: DXS, 1-deoxy-D-xylulose-5-phosphate synthase;
HGGT, homogentisic acid geranylgeranyl transferase; HGO, homogentisic acid dioxygenase; HPPD, p-hydroxyphenylpyruvate dioxygenase; HPT,
homogentisic acid phytyl transferase (VTE2); HST, homogentisic acid solanesyl transferase; G4, chlorophyll synthase; GGPPS11, geranylgeranyl
pyrophosphate synthase 11; GGR, geranylgeranyl reductase; g-TMT, g-tocopherol methyltransferase (VTE4); LIL3, light harvesting-like protein 3;
MT, methyltransferase (VTE3); SPS, solanesyl pyrophosphate synthase; TAT7, tyrosine aminotransferase 7; TC, tocopherol cyclase (VTE1); TyrA,
bifunctional chorismate mutase/prephenate dehydrogenase; VTE5, phytol kinase; VTE6, phytyl phosphate kinase. The direct synthesis of HPP from
chorismate and/or prephenate via the prokaryotic TyrA enzyme (grey arrow) exists in cyanobacteria but not in higher plants.
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synthesis of this precursor in planta have been assessed.
Initial attempts to increase HGA synthesis consisted in
overexpressing HPPD genes (Figure 2a). While HPPD
overexpression slightly increased tocopherol and tocotrie-
nol contents in seeds of transgenic tobacco [47], it did not
substantially increase tocochromanols in tobacco or Ara-
bidopsis leaves, or in Arabidopsis and soybean seeds
[15,47–50]. In contrast, in the cyanobacterium Synechocys-
tis, HPPD overexpression resulted in a sevenfold increase
in tocopherols [15]. The contrasting results of HPPD
overexpression in higher plants and photosynthetic bac-
teria likely results from the difference in HPP biosynthe-
sis between these organisms. While (cyano)bacteria and
yeast produce HPP directly from chorismate and/or pre-
phenate via a bifunctional chorismate mutase/prephenate
dehydrogenase, its biosynthesis in higher plants requires
several enzymatic reactions involving tyrosine as an inter-
mediate [15,16]. Since tyrosine levels are tightly regu-
lated in plant cells via feedback inhibition by tyrosine,
plant tocochromanol biosynthesis may be restricted by
tyrosine availability, whereas photosynthetic bacteria
escape this limitation [13,16]. This hypothesis was
assessed in transgenic plants co-expressing HPPD genes
together with bacterial or yeast prephenate dehydro-
genases (TyrA and Tyr1, respectively). In Arabidopsis
and tobacco leaves, overexpression of HPPD alone did
not alter tocopherol contents but its co-expression with
TyrA or Tyr1 induced a twofold and 10-fold increase in
tocochromanols, respectively [48,50]. This indicates that
HGA availability limits tocochromanol synthesis in leaves
of these two species. In seeds, co-expression of HPPD and
TyrA increased tocochromanol amounts in Arabidopsis
(+80%), canola (+140%), and soybean (+160%), indicating
that HGA availability also partially restricts tocochroma-
nol biosynthesis in seeds [15]. Importantly, newly syn-
thesized tocochromanols in plants co-expressing HPPD
and TyrA genes were mostly tocotrienols, including in
species or tissues that usually do not accumulate them
[15,48,50]. This indicates that HGA availability restricts
tocotrienol synthesis but is not sufﬁcient per se to enhance
tocopherol synthesis.
In Arabidopsis and soybean seeds, co-expression of HPPD
and TyrA increased free HGA content 60-fold and 800-
fold, respectively [15]. Since newly synthesized HGA is
only partially converted into tocochromanols, these data
collectively show that HGA availability is one of several
limitations that restrict tocochromanol biosynthesis in
plants. This was further demonstrated by overexpressing
additional vitamin E biosynthetic gene(s) into high-HGA
transgenic plants [15]. For instance, HPT overexpression
in high-HGA Arabidopsis and soybean further increased
tocochromanol synthesis [15]. The highest tocochroma-
nol increase (15-fold) was reported for high-HGA soy-
beans in which both HPT and GGR were further over-
expressed [15]. In these latter examples, newly produced
tocochromanols were mostly tocotrienols conﬁrming that
seed tocopherol biosynthesis is not limited in the ﬁrst
place by HGA availability.
A novel mechanism limiting HGA availability and toco-
chromanol metabolism has been recently identiﬁed in the
soybean MO12 mutant [51]. This deletion mutant
notably lacks HGO1, a gene encoding an HGA dioxygen-
ase that catalyzes the degradation of HGA into 4-maley-
lacetoacetate (Figure 2a). Since free HGA levels partially
control tocochromanol biosynthesis, its degradation by
HGA dioxygenase might potentially limit vitamin E
biosynthesis. Indeed, MO12 mutant seeds contained
30 times higher HGA amounts and twice as much toco-
chromanols [51]. As for high-HGA transgenic plants,
tocotrienol content was strongly enhanced in MO12
mutant seeds, while tocopherols were unchanged. Col-
lectively these data demonstrate that soybean HGA
dioxygenase restricts tocochromanol synthesis in seeds
by degrading HGA. In addition, it further demonstrates
that increasing only HGA availability is not sufﬁcient to
boost tocopherol synthesis in seeds.
Transgenic approaches targeting the isoprenoid side chain
synthesis
Several transgenic approaches targeting PPP synthesis
have been assessed in plants. It has been shown that
Arabidopsis lines overexpressing the phytol kinase gene
(VTE5) accumulated wild-type tocopherol amounts in
transgenic seeds [20]. In addition, Arabidopsis transgenic
lines overexpressing the phytyl phosphate kinase gene
(VTE6) accumulated at best 15% more g-tocopherol in
seeds [21]. Together, these data show that the conver-
sion of phytol into PPP is not a signiﬁcant bottleneck in
vitamin E synthesis, at least in Arabidopsis seeds.
Because phytol has been shown to be limiting, these data
suggest that pathway(s) involved in GGPP synthesis, and/
or chlorophyll degradation, and/or the reduction of GGPP
into PPP might regulate isoprenoid availability in plants,
and therefore tocochromanol synthesis. The ﬁrst hypoth-
esis has been partially demonstrated in transgenic Arabi-
dopsis in which overexpression of the 1-deoxy-D-xylulose 5-
phosphate synthase (DXS), the ﬁrst enzyme of the MEP
pathway (Figure 2b), doubled tocopherol content in
transgenic Arabidopsis seedlings [52]. It was later shown
that DXS overexpression in mature Arabidopsis leaves did
not signiﬁcantly alter isoprenoid contents, indicating that
DXS activity might be limiting only in young tissues [53].
A second mechanism controlling PPP availability has
been identiﬁed in tobacco in which the constitutive
expression of CHL P, a gene encoding a GGR, induced
a sixfold increase of tocopherols in leaves and a threefold
increase in seeds (Patent US 6,624,342 B1). To date,
these amounts are the highest tocopherol increases ever
reported in both seeds and leaves, indicating that reduc-
tion of GGPP into PPP is likely the most limiting step of
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tocopherol biosynthesis in plants, more so than HPT
activity or HGA availability. This conclusion is in agree-
ment with the results of the high-HGA transgenic plants
overexpressing both HPPD and TyrA or Tyr1 that accu-
mulated mainly unsaturated tocochromanols (tocotrie-
nols) rather than saturated ones (tocopherols)
[15,48,50]. However, these data still do not explain
why high-HGA transgenic soybeans expressing GGR
overaccumulated tocotrienols instead of tocopherols [15].
Conclusions & future challenges
During the last two decades, very signiﬁcant progress has
been made on our understanding of vitamin E biosynthe-
sis in photosynthetic organisms and a total of 19 different
genes that impact or are required for tocochromanol
synthesis have been identiﬁed in plants (Figure 2). Sev-
eral strategies have been undertaken to improve vitamin
E content in crops. To date, the overexpression of the
g-TMT gene is by far the most potent method available.
Regardless of the host or the transgene origin, g-TMT
overexpressors and naturally elevated expression in high
a-tocopherol accessions exhibit the highest vitamin E
increases thus far reported in plants.
The numerous metabolic engineering studies published
so far greatly improved our understanding of both toco-
trienol and tocopherol metabolisms in plants. In species
naturally producing tocotrienols such as monocot seed,
tocotrienol content is strongly restricted by HGGT expres-
sion. In contrast, tocopherol content is not strongly
affected by HPT overexpression in seeds. In addition,
the massive accumulation of tocotrienols rather than
tocopherols in transgenic plants overaccumulating free
HGA or overexpressing HGGT demonstrated that tocoph-
erol synthesis is not primarily regulated by the availability
of free HGA. Since phytyl pyrophosphate mostly comes
from the degradation and recycling of chlorophylls, at
least in senescent leaves and seeds accumulating chlor-
ophylls such as Arabidopsis, it suggests that identifying
the genes and regulatory mechanism(s) involved in chlo-
rophyll turnover will likely open up new horizons for
vitamin E biofortiﬁcation of crops. This new frontier
might be challenging since chlorophylls are essential
for plant survival and metabolism and their biosynthesis
and turnover are both tightly regulated in plant tissues.
This also questions the origin of phytol/phytyl pyrophos-
phate and tocopherol synthesis in species whose seeds do
not produce chlorophylls.
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